HCPLive

Medical News

Latest Medical News

Liver Cancer Target Found
Liver Cancer Target Found
Researchers believe they have found a novel therapeutic to target a growth factor pathway that plays a role in liver cancer.
New Drug for Nonalcoholic Steatohepatitis
Another investigational diabetes drug appears to have promise for patients with nonalcoholic steatohepatitis, researchers reported at the International Liver Congress in Vienna, Austria.
Hepatitis C: Testing Has a Long Way to Go
The explosion in new drugs to treat hepatitis C is leading to predictions the viral infection will no longer be a major health problem. But before that can happen, much has to be done in the realm of public health, researchers said April 25 at the International Liver Congress in Vienna, Austria.
Alcohol Use Predicts Hepatitis C Deaths
In addition to injection drug use, alcohol consumption puts people at risk of dying from hepatitis C infection by increasing the severity of the disease. A French research study spells out the risks.
Weaning Transplant Patients from Immunosuppressive Drugs
The assumption used to be that after a liver transplant patients would need to take immunosuppressive drugs for years, even for life. A team of German researchers say that for about half of adult patients, that is no longer true.
ALLY-1 Results: More Good News on Hep C
As good news about new treatments for hepatitis C infections continues to dominate the 2015 International Liver Congress, Texas researchers today reported more success with sofosbuvir and daclatasvir.
Weighing Liver Transplants for Polycystic Patients
One cure for polycystic liver disease is a liver transplant—but since the disease is not fatal (the liver continues to do its job despite the problems the condition causes for patients), physicians face a treatment dilemma. A Belgian team offers an objective way to make the decision.

Product News

FDA Approves Kidney Failure Device
FDA Approves Kidney Failure Device
FDA approves device to help kidney failure patients with dialysis-related-amyloidosis. Known as the Lixelle Beta-2 microglobulin Apheresis Column, the device is already in use in Japan, where it is manufactured.
First Biosimilar Approved
The US Food and Drug Administration (FDA) approved its first biosimilar product filgrastim-sndz (Zarxio/Sandoz), a cancer drug that is similar to Amgen’s filgrastim (Neupogen).
FDA Warning: Testosterone Can Kill
Manufacturers of prescription testosterone products must change their drug labels to include a warning about increased risk of heart attacks and strokes. The labeling change, announced today by the US Food and Drug Administration (FDA) addresses the use of testosterone by men whose decreased level of the hormone is due to aging.
CDC Adds Gardasil 9 to Routine Vaccination List
The US Centers for Disease Control and Prevention (CDC) advisory committee on immunization practices today approved including Merck's Gardasil 9 vaccine in a list of recommended vaccinations for children and young adults. The vaccine got US Food and Drug Administration (FDA) approval in December, 2014. The vaccine is an improvement on the older version of Gardasil in that it offers protection against 5 more types of Human Papillomavirus (HPV) than the original product.
New Antibacterial Approved for Complex Infections
The US Food and Drug Administration (FDA) approved a new antibacterial drug combination product, ceftazidime-avibactam (Avycaz/Forest Labs), for use in complicated intra-abdominal infections.

Most Popular

$vacMongoViewPlus$ $vAR$